CINECA IRIS Institutional Research Information System

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)

Nathan P.;Ascierto P. A.;Haanen J.;Espinosa E.;Demidov L.;Garbe C.;Guida M.;Lorigan P.;Chiarion-Sileni V.;Gogas H.;Maio M.;Fierro M. T.;Hoeller C.;Terheyden P.;Gutzmer R.;Guren T. K.;Bafaloukos D.;Rutkowski P.;Plummer R.;Waterston A.;Kaatz M.;Mandala M.;Marquez-Rodas I.;Munoz-Couselo E.;Dummer R.;Grigoryeva E.;Young T. C.;Schadendorf D.

2019-01-01